The Oxford University AstraZeneca Covid-19 vaccine trial has been paused – should we be worried?

Is this the end for hopes of an early breakthrough in the race to find a coronavirus drug?

The halt in development of the University of Oxford’s Covid-19 vaccine due to an adverse reaction in a trial participant has triggered fears of a delay in finding a solution to coronavirus restrictions.

A spokesman for AstraZeneca, the company working with the academic team to produce the vaccine, said the voluntary pause is “routine”.

Continue reading…